Literature DB >> 10197808

Fatal outcome due to cyclosporine neurotoxicity with associated pathological findings.

A K Gopal1, D R Thorning, A L Back.   

Abstract

We present a case of death likely to be directly due to cyclosporine (CsA) neurotoxicity. To date, there have been no reports of deaths directly due to CsA neurotoxicity, nor has an associated histological lesion been described independent of confounding processes. A 54-year-old male received an HLA-matched-unrelated BMT for CML. He developed progressive encephalopathy and on day +79 had a generalized seizure. All CSF studies were negative for infectious causes. MRI revealed diffuse, symmetrical white matter abnormalities located in the occipital sub-cortex, thalamus, mid brain, pons, and cerebellum which were typical of CsA toxicity. The patient died of central respiratory failure within 72 h of discontinuing CsA. Autopsy revealed diffuse patchy white matter edema and astrocytic injury without evidence of axonopathy, demyelination, microvascular injury, or infectious/inflammatory process. This case demonstrates previously undescribed lethal CsA neurotoxicity and may reveal an associated primary pathological lesion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197808     DOI: 10.1038/sj.bmt.1701542

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  2 in total

1.  High-fat diets impede the lowering effect of cyclosporine A on rat brain lipids and interact with the expression of apolipoproteins E and J.

Authors:  Pascale Montpied; Nicole Domingo; Michèle Senft; Henri Portugal; Pierre Petit; Françoise Chanussot
Journal:  Lipids       Date:  2005-01       Impact factor: 1.880

2.  Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation.

Authors:  Stephanie Campbell; Can-Lan Sun; Seira Kurian; Liton Francisco; Andrea Carter; Sameer Kulkarni; Pablo Parker; Chatchada Karanes; Stephen J Forman; Smita Bhatia
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.